InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,674.00
(
0.16%
)
Dow Jones
39,308.00
(
0.00%
)
Brent Oil
87.08
(
-0.29%
)
Bitcoin
55,472.18
(
-2.65%
)
Post# of 463451
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

frrol

Send PM Follow Ignore
Followers 91
Posts 11360
Boards Moderated 0
Alias Born 06/06/2014

frrol

Re: Investor2014 post# 338755

Sunday, 12/05/2021 9:06:23 AM

Sunday, December 05, 2021 9:06:23 AM

Post# of 463451
The company combed the living hell out of the AD phase 2A data, extracting whatever information they could pull of it. The same is being done to our Rett and PDD data. It's good to see. For AD, we wanted to understand why some didn't apparently respond, why some did, and why a couple seemed to respond strongly. The dosage wasn't a good clue, so we went to genomic-sequencing, KEM analysis, and mRNA biomarking. We are doing this with all our trials now (our "precision medicine" approach), which is a sensible idea. It helps with trial design, regulatory reviews, and perhaps future participant (and patient) selection.

None of this matters of course without efficacy signal. Keep eyes out for trial results.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!